GSK
GSK plcCompany with tickers: GSK, GLAXF
CIK
1131399
CUSIP
37733W204
Shares Outstanding
2,004,414,458
Website
https://www.gsk.com/
Investor Relations
https://www.gsk.com/investor-relations
13F Activity (30d)
43 filings
31 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2025-04-15 | — | |
| 6-K | 2025-04-14 | — | |
| 6-K | 2025-04-11 | — | |
| 6-K | 2025-04-10 | — | |
| 6-K | 2025-04-09 | — | |
| 6-K | 2025-04-08 | — | |
| 6-K | 2025-04-07 | — | |
| 6-K | 2025-04-04 | — | |
| 6-K | 2025-04-03 | — | |
| 6-K | 2025-04-02 | — | |
| 6-K | 2025-04-01 | — | |
| 6-K | 2025-03-31 | — | |
| 6-K | 2025-03-28 | — | |
| 6-K | 2025-03-27 | — | |
| 6-K | 2025-03-26 | — | |
| 6-K | 2025-03-25 | — | |
| 6-K | 2025-03-24 | — | |
| 6-K | 2025-03-21 | — | |
| 6-K | 2025-03-20 | — | |
| 6-K | 2025-03-19 | — | |
| 6-K | 2025-03-18 | — | |
| 6-K | 2025-03-17 | — | |
| 6-K | 2025-03-14 | — | |
| 6-K | 2025-03-13 | — | |
| 6-K | 2025-03-12 | — | |
| 6-K | 2025-03-11 | — | |
| 6-K | 2025-03-10 | — | |
| 6-K | 2025-03-07 | — | |
| 6-K | 2025-03-06 | — | |
| 6-K | 2025-03-05 | — | |
| 6-K | 2025-03-04 | — | |
| 20-F | 2025-03-03 | 2024-12-31 | |
| 6-K | 2025-03-03 | — | |
| 6-K | 2025-02-28 | — | |
| 6-K | 2025-02-27 | — | |
| 6-K | 2025-02-26 | — | |
| 6-K | 2025-02-25 | — | |
| 6-K | 2025-02-24 | — | |
| 6-K | 2025-02-21 | — | |
| 6-K | 2025-02-20 | — | |
| 6-K | 2025-02-18 | — | |
| 6-K | 2025-02-13 | — | |
| 6-K | 2025-02-11 | — | |
| 6-K | 2025-02-05 | — | |
| 6-K | 2025-02-03 | — | |
| 6-K | 2025-01-28 | — | |
| 6-K | 2025-01-27 | — | |
| 6-K | 2025-01-21 | — | |
| 6-K | 2025-01-16 | — | |
| 6-K | 2025-01-15 | — |
Showing 251–300 of 837 filings